XML 49 R28.htm IDEA: XBRL DOCUMENT v3.24.1
Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2023
Shareholders’ Equity [Abstract]  
Schedule of Stock Option Activity A summary of the stock option activity under the Company’s equity plans during the years ended December 31, 2023, 2022 and 2021 is as follows:
  

Outstanding

share options

   Weighted-average exercise
price ($)
   Weighted average remaining contractual
life (years)
   Aggregate intrinsic value ($ in thousands) 
Options:                
                 
Outstanding as of December 31, 2020   3,768,034    0.767    4.626    119,146 
                     
Granted   1,966,916    7.250           
Forfeited   (117,863)   0.972           
Exercised   (155,750)   0.602           
                     
Outstanding as of December 31, 2021   5,461,337    3.102    5.363    16,713,971 
                     
Granted   1,630,142    6.833           
Forfeited   (468,814)   5.557           
Exercised   (570,451)   0.482           
                     
Outstanding as of December 31, 2022   6,052,214    4.166    5.570    7,761,705 
                     
Granted   430,874    2.728           
Forfeited   (351,671)   7.767           
Exercised   (1,074,162)   0.654           

 

Outstanding as of December 31, 2023

   5,057,255    4.543    5.662    2,352,517 
                     
Exercisable as of December 31, 2023   3,210,191    3.643    4.403    2,277,303 
                     
Options available for future grants   611,246                

 

Schedule of RSUs Activity A summary of the Company’s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:
   Numbers of RSUs 
RSUs:    
     
Outstanding as of January 1, 2021   - 
      
Granted   1,968,794 
Forfeited   - 
Vested   - 
Outstanding as of December 31, 2021   1,968,794 
      
Granted   1,619,898 
Forfeited   (417,025)
Vested   (573,583)
      
Outstanding as of December 31, 2022   2,598,084 
      
Granted   2,908,983 
Forfeited   (370,067)
Vested   (895,170)
      
Outstanding as of December 31, 2023   4,241,830 
Schedule of Compensation to Employees The following table sets forth the parameters used in computation of the options compensation to employees and service providers:
  

Year ended

December 31

 
   2023   2022   2021 
             
Expected term, in years   5.82    4.41-6.11    4.61-6.11 
Expected volatility   47%-51.75%    47%-48%    42%-46% 
Risk-free interest rate   4.15%-4.55%    1.74%-3.96%    0.49%-1.28% 
Expected dividend yield   0%   0%   0%

 

Schedule of Share Based Compensation Expense The following table presents stock-based compensation expense to employees included in the Company’s consolidated statements of operations:
  

Year ended

December 31,

 
   2023   2022   2021 
             
Research and development  $8,721   $5,726   $1,518 
Sales and marketing   2,229    1,403    217 
General and administrative   1,786    1,537    419 
Cost of revenues   276    127    57 
Total stock-based compensation expense  $13,012   $8,793   $2,211